GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2007

Researchers Identify Molecule Associated with Flu Lethality

  • A protein in influenza A virus (IAV)   increases the deadliness of resulting bacterial infections, according to researchers at the department of infectious diseases at St. Jude Children’s Research Hospital.

    Investigators examined the interaction between influenza and bacterial infection by studying a newly discovered IAV protein, PB1-F2. The gene encoding PB1-F2 is present in nearly all IAVs including highly pathogenic avian IAVs that have infected humans and the IAV associated with the 1918 pandemic, report the scientists.

    The researchers found that expression of PB1-F2 increased the incidence of and exacerbated secondary bacterial pneumonia in a mouse model. Intranasal delivery of a synthetic peptide derived from a portion of PB1-F2 had the same effects.

    The team also found that an influenza virus engineered to express a version of PB1-F2 identical to that in the 1918 pandemic strain was more virulent in mice and led to more severe bacterial pneumonia.

    The study appears in the October issue of Cell Host & Microbe.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?